Diabetic Eye Disease 1

Klein R , Klein BEK , Moss SE . The Winsconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102:520–6.

Kein R , Klein BEK , Moss SE . The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102(4):527–32.

Klein R , Klein BEK , Moss SE . Prevalence of diabetes mellitus in South Winsconsin. Am J Epidemiol 1984; 119:54–61.

Khan HA , Bradley RF . Prevalence of diabetic retinopathy. Br J Ophthalmol 1975; 59:345–9.

Segato T , Midena E , Grigoletto F . The epidemiology and prevalence of diabetic retinopathy in the Veneto region of northeast Italy. Veneto Group for Diabetic Retinopathy. Diabet Med 1991; 8:11–16.

Hirvela H , Laatikainen L . Diabetic retinopathy in people aged 70 years or older. The Oula Eye Study. Br J Ophthalmol 1997; 81:214–7.

Mitchell P , Smith W , Wang JJ . Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 1998; 105:406–11.

Neilsen NV . Diabetic Retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 1984; 62(2):266–73.

Kohner EM , Aldington SJ , Stratton IM . United Kingdom Prospective Diabetes Study. Thirty diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116:297–303.

Klein R , Klein BEK , Moss SE . The Beaver Dam Eye Study. Retinopathy in adults with newly-discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992; 99:58–62.

Aldington SJ . Prevalence of retinopathy at diagnosis of type 2 diabetes in the UK Prospective Diabetes Study. Diabet Med 1994; 11(Suppl. 2):43–4.

Group DRSR. Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report No.14. Ophthalmol Clin 1987; 27(4):39–53.

Group DRSR. Indications for photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978; 85(1):82–106.

Group ETDRSR. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1. Arch Ophthalmol 1985; 103(12):1796–1806.

Group ETDRSR. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Report No. 3. Ophthalmol Clin 1987; 27(4):254–64.

Group ETDRSR. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 1991; 98(Suppl. 5):766–85.

Javitt JC , Aiello LP , Chiang Y . Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994; 17(8):909–17.

Dasbach EJ , Fryback DG , Newcomb PA . Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991; 29(1):20–39.

Javitt JC , Aiello LP . Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996; 124(1 pt 2):164–9.

Javitt JC , Canner JK , Frank RG . Detecting and treating retinopathy in patients with type 1 diabetes. Ophthalmology 1990; 97:483–92.

Javitt JC , Canner JK , Sommer A . Cost-effectiveness of current approaches to the control of retinopathy in type 1 diabetics. Ophthalmology 1989; 96(2):255–64.

Scobie IN , MacCuish AC , Barrie T . Serious retinopathy in a diabetic clinic: prevalence and therapeutic implications. Lancet 1981; 2(8245):520–1.

Grey RHB , Malcolm N , O'Reilly D . Ophthalmic survey of a diabetic clinic I: Ocular findings. Br J Ophthalmol 1986; 70:797–803.

Foulds W , McCuish A , Barrie T . Diabetic retinopathy in the West of Scotland: its detection and prevalence and the cost-effectiveness of a proposed screening programme. Health Bull (Edinb) 1983; 41(6):318–26.

Sparrow JM , McLeod BK , Smith TDW . Diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 1993; 7:158–63.

Leese G , Newton R , Jung R . Screening for diabetic retinopathy in a widely spaced population using non-mydriatic fundus photography in a mobile unit. Diabet Med 1992; 9:459–62.

Klein R , Klein BEK , Moss SE . The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema. Ophthalmology 1984; 91:1464–74.

Vitale S , Maguire MG , Murphy RP . Clinically significant macular edema in type 1 diabetes. Ophthalmology 1995; 102:1170–6.

Klein R , Klein BEK , Moss SE . The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV. The long-term incidence of macular edema. Ophthalmology 1995; 102:7–16.

Aiello LP , Gardner TW , King GL . Diabetic retinopathy. Diabetes Care 1998; 21:143–56.

Sharma RA . Diabetic eye disease in Southern India. Comm Eye Health 1996; 9:56–8.

Hamilton AMP , Ulbig MW , Polkinghorne P . Management of diabetic retinopathy. BMJ Publishing Group 1996.

Cunha-Vaz J. Lowering the risk of visual impairment and blindness. Diabet Med 1998; 15(Suppl. 4):47–50.

Ghafour IM , Allen D , Foulds WS . Common causes of blindness and visual handicap in the West of Scotland. Br J Ophthalmol 1983; 67:209–13.

Grey RHB , Burns-Cox CJ , Hughes A . Blind and partial sighted registration in Avon. Br J Ophthalmol 1989; 73:88–94.

Evans J , Rooney C , Ashwood F . Blindness and partial sight in England and Wales: April 1990–March 1991. Health Trends 1996; 28:5–12.

Report of the National Commission on Diabetes to the Congress of the United States Scope and Impact of Diabetes (II). 1981 (NIH DHEW Publ No. 77:1022:15).

Infeld DA, O'Shea JG. Diabetic retinopathy. Postgrad Med J 1998; 74:129–33.

Borch-Johansen K . The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach. Dan Med Bull 1989; 36:336–48.

Trautner C , Icks A , Haastert B . Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997; 20(7):1147–53.

Bruce I , McKennell A , Walker E . Blind and partial sighted adults in Britain. The RNIB Survey I 1991: HMSO.

Evans J. Causes of blindness and partial sight in England and Wales 1990–91:OPCS;1995.

Rhatigan MC , Leese GP , Ellis J . Blindness in patients with diabetes who have been screened for eye disease. Eye 1999; 13(2):166–9.

Dwyer MS III , JLM, Ballard DJ . Incidence of diabetic retinopathy and blindness: a population based study in Rochester, Minnesota. Diabetes Care 1985; 8(4):316–22.

Icks A , Trautner C , Haastert B , Berger M . Blindness due to diabetes: population-based age- and sex-specific incidence rates. Diabet Med 1997; 14:571–5.

Backlund LB , Algvere PV , Rosequist U . New blindness in diabetes reduced by more than one-third in Stockholm country. Diabet Med 1997; 14:732–40.

Beetham WP . Visual prognosis of proliferating diabetic retinopathy. British Journal of Retinopathy 1963; 47:611–19.

Caird FI , Burditt AF , Draper GJ . Diabetic retinopathy: a further study of prognosis for vision. Diabetes 1968; 17:121–3.

Moss SE , KleinR , Klein BEK . Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101(6):1061–70.

Moss SE , Klein R , Klein BEK . The incidence of vision loss in a diabetic population. Ophthalmology 1988; 95(10):1340–48.

Sjolie AK , Green A . Blindness in insulin treated diabetic patients with age of onset <30 years. Journal of Chronic Disease 1987; 40:215–20.

Ulbig MRW , Hamilton AMP . Factors influencing the natural history of diabetic retinopathy. Eye 1993; 7:242–9.

Yamagishi S , Yanekura H , Yamamoto Y . J Biol Chem 1997; 272: 723–30.

Lu M , Kuroki M , Amano S . Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101:1219–24.

Nishimura M , Ikeda T , Ushiyama M . Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1999; 84: 659–62.

Katsura Y , Okano T , Noritake M . Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 1998; 21:1759–63

Press M , Tamborlane WV , Sherwin RS . Importance of raised growth hormone levels in the metabolic derangement of diabetes. N Engl J Med 1984; 310: 810–15.

Meyer-Schwickerath R , Pfeiffer A , Blum WF . Vitreous levels of insulin-like growth factors I and II and the insulin-like growth factor binding proteins 2 and 3 increase in neovascular eye disease. Studies in diabetic and non-diabetic subjects. J Clin Invest 1993; 92:2620–5.

Boulton M , Foreman D , Williams G . VEGF localization in diabetic retinopathy. Br J Ophthalmol 1998; 82:561–8.

Cunha-Vaz JG , Fonseca JR , de-Abreu JR . Studies on retinal blood flow II Diabetic retinopathy. Arch Ophthalmol 1978; 96:809–11.

Taylor RH , Jones HS , Dodson PM . Diabetic eye disease: a natural history study. Eye 1997; 11:547–53.

Mohan R , Mohan V , Susheela L . Increased LDL-cholesterol in non-insulin dependent diabetes with maculopathy. Acta Diabetol 1984; 21:85–9.

Parving HH , Viberti GC , Keen H . Haemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32:943–9.

DCCT Research Group. Results of feasibility study. Diabetes Care 1987; 10:1–19.

Patel V , Rassam S , Newsom R . Retinal blood flow in diabetic retinopathy. BMJ 1992; 305:678–83.

Shore AC , Japp AJ , Tooke JE . Capillary pressure in patients with NIDDM. Diabetes 1994; 43:1198–1202.

Moller M , Orskov H . Does IGF-1 therapy in insulin dependent diabetes limit complications? Lancet 1997; 350:1188–9.

Sharp PS , Fallon TJ , Brazier OJ . Long-term follow-up of patients who underwent yttrium-90 pituitary implanation for treatment of proliferative retinopathy. Diabetol 1987; 33:199–207.

Amiel SA , Herwin RS , Hintz RL . Effects of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes mellitus. Diabetes 1984; 33:1175–9.

Acerini CL , Patton CM , Savage MO . Randomized placebo-controlled trial of human recombinant insulin like growth factor I plus intensive insulin therapy in adolescents with insulin dependent diabetes mellitus. Lancet 1997; 350:1199–1204.

Wautier JL , Paton RC , Wautier MP . Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981; 305:237–42.

DCCT Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997; 46(11):1829–39.

Agardh D , Agardh E , Gaur LK . HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 1996; 39:1313–7.

The Royal College of Ophthalmologists guidelines for diabetic retinopathy 1997. The Royal College of Ophthalmologists, 17 Cornwall Terrace, London.

Kohner EM, Sleightholm M. Does the microaneurysm count reflect the severity of early diabetic retinopathy? Ophthalmol 1986; 93:586–9.

Klein R , Meuer SM , Moss SE . Retinal microaneurysm counts and 10–year progression of diabetic retinopathy. Arch Ophthalmol 1995; 113:1386–91.

Mapstone R , Clark CV . Prevalence of diabetes in glaucoma. BMJ 1985; 291:93–5.

Dielemans I , de Jong PTVM , Stolk R . Primary open-angle glaucoma, Intraocular Pressure, and Diabetes Mellitus in the general elderly population. The Rotterdam study. Ophthalmology 1996; 103:1271–5.

Mitchell P , Smith W , Chey T . Open-angle glaucoma and diabetes. The Blue Mountains Eye Study. Ophthalmology 1997; 104:712–8.

Klein BEK . Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmolgy 1994; 101:1173–7.

Tielsch JM , Katz J , Quigley HA . Diabetes, intraocular pressure, and primary open angle glaucoma in the Baltimore eye survey. Ophthalmology 1995; 102:44–53.

Klein R , Klein BEK , Moss SE . Glycosylated hemoglobin predicts the incidence and the progression of diabetic retinopathy. JAMA 1988; 260:2864–71.

Diabetes control and complications trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–86.

UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837–53.

Klein R , Klein BEK , Davis MD . Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 1983; 118:228–38.

Mulhauser I , Bender R , Bott U . Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diab Med 1996; 13:536–43.

Klein R , Klein BEK , Moss SE . The Wisconsin epidemiological study of diabetic retinopathy XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801–15.

Cignarelli M . High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992; 15:1002–8.

Sjolie AK , Stephenson J , Aldington S . Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM complications study. Ophthalmology 1997; 104:252–60.

Dowse GK , Humphrey AR , Collins VR . Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998; 147:448–57.

Chen MS , Kao CS , Chang CJ . Prevalence and risk factors of diabetic retinopathy among non-insulin dependent diabetic subjects. Am J Ophthalmol 1992; 114:723–30.

Klein R , Klein BE , Moss SE . The relation of systemic hypertension to changes in the retinal vasculature: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1997; 95:329–48.

Yu T , Mitchell P , Berry G . Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998; 116:83–9.

UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in diabetes. UKPDS 38. BMJ 1998; 317:703–13.

Chen HC , Newsome RSB , Patel V . Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 1994; 35: 3199–3208.

Clark JB , Grey RH , Lim KK . Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol 1994; 78:741–4.

Rohan TE , Frost CD , Wald NJ . Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 1989; 299:1198–1201.

Kohner EM , Barry PJ . Prevention of blindness in diabetic retinopathy. Diabetologia 1984; 26:173–9.

Bagga P , Verma D , Walton C . Survey of diabetic retinopathy screening services in England and Wales. Diabet Med 1998; 15:780–2.

Buxton MJ , Sculpher MJ , Fergusson BA . Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med 1991; 8:371–7.

Harding SP , Broadbent DM , Neoh C . Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight-threatening eye disease. The Liverpool diabetic eye study. BMJ 1995; 311:1131–5.

Lairson DR , Pugh JA , Kapadia AS . Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 1992; 15: 1369–77. 103 Taylor R, Lovelock L, Tunbridge W et al. Comparison of non-mydriatic polaroid photograpgy with ophthalmoscopy in 2,159 patients mobile retinal camera study. BMJ 1990; 301:1243–7.

Jones D , Dolben J , Owens DR . Non-mydriatic polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting. BMJ 1988; 296:1029–30.

Mohan R , Kohner E , Aldington S . Evaluation of a non-mydriatic camera in Indian and European diabetic patients. Br J Ophthalmol 1988; 72:841–4.

Williams R , Nussey S , Humphreys R . Assessment of non- mydriatic fundus photography in detection of diabetic retinopathy. Br Med J 1986; 293:1140–2.

Taylor R . Practical community screening for diabetic retinopathy using the mobile retinal camera: Report of a 12-centre study. Diabet Med 1996; 13:946–52.

Leese GP , Ahmed S , Newton RW . Use of mobile screening unit for diabetic retinopathy in rural and urban areas. B J 1993; 306:187–9.

Leese GP , Broadbent DM , Harding SP . Detection of diabetic eye disease. Diabet Med 1996; 13:850–3.

Ryder RE , Kong N , Bates AS . Instant electronic imaging systems are superior to polaroid at detecting sight-threatening retinopathy. Diabet Med 1998; 15:254–8.

Harrison RJ , Wild JM , Hobbley AJ . Referral patterns to an ophthalmic outpatient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease. Br Med J 1988; 297: 1162–7.

Hammond RJ , Shackleton J , Flanagan DW . Comparison between an ophthalmic optician and an ophthalmologist in screening for diabetic retinopathy. Eye 1996; 10:107–12.

Burns-Cox C , Dean Hart JC . Screening of diabetics for retinopathy by ophthalmic opticians. BMJ 1985; 290:1052–4.

Gatling W , Howie AJ , Hill RD . An optical practice based diabetic eye screening programme. Diabet Med 1995; 12:531–6.

Kerr D , Jennings B , Cavan C . Beyond retinal screening. Digital imaging in the assessment and follow-up of patients with diabetic retinopathy. Diabet Med 1998; 15:878–82.

Burnett S , Hurwitz B , Davey C . The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med 1998; 15(Suppl. 3):S38–43.

Leese GP , Tesfaye S , Dengler-Harles M . Screening for diabetic eye disease by optometrists using slit lamps. J Roy Coll Physicians Lon 1997; 31:65–9.

Ryder B . Screening for diabetic retinopathy. BMJ 1995; 311: 207–8.

Jacob J , Stead J , Sykes J . A report on the use of technician ophthalmoscopy combined with the use of the canon non-mydriatic camera in screening for diabetic retinopathy in the community. Diabet Med 1995; 12:419–25.

O'Hare JP , Hopper A , Madhaven C . Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ 1996; 312:679–82.

Gibbins RL , Owens DR , Allen JC . Practical application of the European field guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 1998; 41:59–64.

Ryder RE , Close CF , Krentz AJ . A ‘fail-safe’ screening programme for diabetic retinopathy. J Roy Coll Physicians Lon 1998; 32:34–7.

Diamond JP , McKinnon M , Barry C . Non-mydriatic fundus photography: a viable alternative to funduscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia. Aust N Z J Ophthalmol 1998; 26:109–15.

Owens DR , Gibbins RL , Lewis PA . Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies? Diabet Med 1998; 15:170–5.

Higgs ER , Harney BA , Kelleher A . Detection of diabetic retinopathy in the community using a non-mydriatic camera. Diabet Med 1991; 8:551–5.

Hirvela H , Laatikainen L . Diabetic retinopathy in people aged 70 years or older. The Oulu eye study. Br J Ophthalmol 1997; 81:214–17.

Sculpher M , Buxton M , Fergusson B . A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med 1991; 8:644–50.

Sculpher M , Buxton M , Fergusson B . Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1992; 1:39–51.

The British multicentre study group. Proliferative diabetic retinopathy: treatment with Xenon-arc photocoagulation. Interim report of multicentre randomized controlled trial. BMJ 1977; 1:739–41.

Early treatment of diabetic retinopathy study. Photocoagulation for diabetic macula oedema: report IV. Int Ophthalmol Clin 1987; 27:265–72.

Stefaniotou M , Kalogeropoulos C , Psilas K . Long-term visual results after laser photocagulation for diabetic maculopathy. Ophthalmologica 1995; 209:64–7.

Ferris FL . How effective are treatments for diabetic retinopathy? JAMA 1993; 269: 290–1.

Cordeiro MF , Standford MR , Phillips PM . Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye 1997; 11:531–6.

Bailey CC , Sparrow JM , Grey RHB . The national diabetic retinopathy laser treatment audit. I Maculaopthy. Eye 1998; 12:69–76.

Henricsson M , Heijl A , Janzon L . Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996; 80: 789–93. 136 Chiu DW, Meusemann RA, Kaufman DV et al. Visual outcome and progression of retinopathy after cataract surgery in diabetic patients. Aust N Z J Ophthalmol 1998; 26:29–33.

West JA , Dowler JGF , Hamilton AMP . Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease. Eye 1999; 13:170–3.

Jones RB , Larizgoita I , Casado L . How effective is the referral chain for diabetic retinopathy? Diabet Med 1989; 6:262–6.

Bailey CC , Sparrow JM , Grey RHB . The national diabetic retinopathy laser treatment audit. II Proliferative retinopathy. Eye 1998; 12:77–84.

Early vitrectomy for severe vitreous haemorrhage in diabetic retinopathy. Two year results of a randomized trial: Diabetic retinopathy vitrectomy study report 2. Arch Ophthalmol 1985; 103:1644–52.

Early worsening of diabetic retinopathy in the diabetes control and complications trial. DCCT. Arch Ophthalmol 1998; 116:874–86.

Chaturvedi N , Sjolie AK , Stephenson JM . Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351:28–31.

van der Pijl JW , van der Woude FJ , Swart W . Effect of danaparoid sodium on hard exudates in diabetic retinopathy. Lancet 1997; 350:1743–5.

Frank RN . The aldose reductase controversy. Diabetes 1994; 43:169–72.

Hammes HP , Brownlee M , Edelstein D . Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 1994; 37:32–5.

Skolnick AA . Novel therapies to prevent diabetic retinopathy. JAMA 1997; 278:1480–1.